Health & Wellness BeOne Medicines gets positive stock bump on RBC Capital upgrade Analysts see strong upside potential in BeOne’s move into solid tumours Joseph Morton6 days ago
Medical and Pharmaceutical Cizzle Bio submits NIH grant proposal for biomarker blood test for lung cancer The study will analyze pre-diagnostic and longitudinal blood plasma samples from the PLCO Cancer Screening Trial Joseph MortonJuly 14, 2025
AI and Autonomy SimBioSys gets FDA nod for AI breast cancer platform The platform's latest update represents the next evolution of a clinically validated platform designed to improve consistency, precision, and efficiency Joseph MortonJuly 10, 2025
AI and Autonomy New artificial intelligence tech allows for digital mapping of tumours iSeg uses 3D imagery to provide a deeper understanding of tumours Joseph MortonJuly 7, 2025
Medical and Pharmaceutical Guardant Health gets Breakthrough Device Designation from FDA for cancer detection test The FDA grants Breakthrough Device designation to devices that may offer more effective treatment or diagnosis of serious conditions like cancer Joseph MortonJune 24, 2025
AI and Autonomy The dual nature of artificial intelligence: A Mugglehead roundup AI is not inherently good or bad—it is a tool, shaped by how we choose to use it Joseph MortonJune 20, 2025
Medical and Pharmaceutical Breathe BioMedical adds research site to breast cancer breath test study The Canadian company aims to provide an accurate screening measure for women with dense breast tissue Rowan DunneJune 18, 2025
Medical and Pharmaceutical Against the rise of early onset cancer: a Mugglehead roundup Cancer treatment markets are set to expand rapidly over the next decade Joseph MortonMay 29, 2025
Medical and Pharmaceutical Lucid Diagnostics joins Russell 2000 and 3000 indexes Investment managers and institutional investors widely use the Russell indexes for both index funds and active investment benchmarks Joseph MortonMay 27, 2025
Medical and Pharmaceutical Phase Scientific International advances urine biopsy tech with $34M fundraising round The company has gained strong market traction by launching over 30 diagnostic products across multiple health categories Joseph MortonMay 26, 2025